ELMELECH IDAN (COO & Principal Financial Ofcr) reported 1 transaction at BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/5/2026ACC: 0001193125-26-414131
Officer· COO & Principal Financial Ofcr
Since Apr 2026
-343.00
Net shares
Net seller
$1.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
343.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−343.00
Price / share
$3.94
Trade value
$1.35K
% of position
2.4%
10/1/2026
14.49K→14.15K
Total
Net shares
−343.00
Net value
-$1.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2026 | F · Tax Withholding | −343.00 | $3.94 | $1.35K | 2.4% | 14.49K | 14.15K |
| Total | −343.00 | -$1.35K | ||||||
Derivative Transactions0
No derivative transactions reported